Cardiovascular Health in Pediatric Rheumatologic Diseases

Kaveh Ardalan1, Donald M Lloyd-Jones2, Laura E Schanberg3

  • 1Department of Pediatrics, Division of Pediatric Rheumatology, Duke University School of Medicine, T909 Children's Health Center, DUMC Box 3212, Durham, NC 27710, USA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago.

Insights

Children with rheumatic diseases like juvenile lupus face significant cardiovascular disease risk. Addressing inflammation and improving heart health through interventions is crucial for better long-term outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Cardiovascular Health
  • Public Health

Background:

  • Children with juvenile systemic lupus erythematosus, juvenile dermatomyositis, and juvenile idiopathic arthritis exhibit increased cardiovascular disease risk.
  • Cardiovascular health, defined by the American Heart Association, encompasses protective factors against heart disease.
  • Chronic inflammation and endothelial dysfunction in rheumatic diseases contribute to elevated cardiovascular risk.

Purpose of the Study:

  • To highlight the cardiovascular disease risk in pediatric rheumatic diseases.
  • To emphasize the link between disease-related factors and cardiovascular health.
  • To underscore the need for interventions to improve cardiovascular outcomes in affected children.

Main Methods:

  • Literature review on cardiovascular risk in pediatric rheumatic diseases.
  • Analysis of the relationship between inflammation, endothelial dysfunction, and cardiovascular health.
  • Identification of gaps in current management strategies.

Main Results:

  • Juvenile rheumatic diseases are associated with early-onset cardiovascular disease risk.
  • Disease mechanisms directly and indirectly impair cardiovascular health.
  • Existing research indicates a need for targeted cardiovascular interventions.

Conclusions:

  • Children with juvenile idiopathic arthritis, juvenile dermatomyositis, and juvenile systemic lupus erythematosus require proactive cardiovascular risk management.
  • Interventions targeting chronic inflammation and endothelial dysfunction are essential.
  • Pharmacologic and nonpharmacologic strategies are needed to improve cardiovascular health and long-term outcomes in pediatric rheumatic diseases.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
87
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
114
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
65
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
53
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
107
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30